Magnesium Glycinate
Magnesium deficiency can worsen torsades risk in patients receiving QT-prolonging drugs such as haloperidol.
Recommendation: Correct low magnesium under clinician guidance when QT risk factors are present.
Prescription ·Strong evidence ·Reviewed May 2026
Haloperidol is a high-potency first-generation antipsychotic used for schizophrenia, Tourette disorder, and acute agitation or delirium-related severe behavioral disturbance when clinically appropriate. It has substantial extrapyramidal, tardive dyskinesia, neuroleptic malignant syndrome, and QT-prolongation risks, especially with high doses or parenteral use. It carries a boxed warning for increased mortality in elderly patients with dementia-related psychosis.
The bottom line
Evidence rating strong. Most-documented uses: treatment of schizophrenia, control of tics and vocal utterances in tourette disorder, short-term management of severe acute agitation when benefits outweigh risks. 3 sources indexed (2020–2026), with 4 interaction records on file.
Core mechanism
Haloperidol primarily antagonizes dopamine D2 receptors in mesolimbic and nigrostriatal pathways, producing antipsychotic effects and extrapyramidal adverse effects. It has less anticholinergic and antihistaminic activity than low-potency antipsychotics but can cause marked dopamine blockade, hyperprolactinemia, akathisia, dystonia, parkinsonism, and tardive dyskinesia. Cardiac potassium-channel effects contribute to QT prolongation and torsades risk, especially with IV use, high doses, electrolyte abnormalities, or other QT-prolonging drugs.2,3
Oral haloperidol can be taken with or without food. Avoid alcohol and use caution with other sedating agents.
Magnesium deficiency can worsen torsades risk in patients receiving QT-prolonging drugs such as haloperidol.
Recommendation: Correct low magnesium under clinician guidance when QT risk factors are present.
Hypokalemia increases risk of QT-related ventricular arrhythmias during haloperidol therapy.
Recommendation: Correct hypokalemia medically and avoid unsupervised potassium supplementation in kidney disease or with potassium-retaining drugs.
Melatonin can add to haloperidol-related sedation, dizziness, and psychomotor impairment.
Recommendation: Use cautiously and monitor for falls or next-day impairment.
Ginkgo has seizure case reports, and haloperidol can lower seizure threshold in susceptible patients.
Recommendation: Avoid or use cautiously in patients with seizure disorders or other seizure-threshold-lowering exposures.
Numbered references. Citations throughout the page link here.
Guideline supports monitoring antipsychotic efficacy, abnormal movements, metabolic parameters, and cardiovascular risk.
Decanoate labeling describes maintenance use in adults previously stabilized on immediate-release haloperidol.
Labeling lists contraindications, dementia-related psychosis boxed warning, QT risk, and extrapyramidal adverse effects.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.